These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34022704)

  • 1. Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer's disease: A preclinical evidence.
    Saini S; Sharma T; Jain A; Kaur H; Katare OP; Singh B
    Colloids Surf B Biointerfaces; 2021 Sep; 205():111838. PubMed ID: 34022704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation.
    Akel H; Ismail R; Katona G; Sabir F; Ambrus R; Csóka I
    Int J Pharm; 2021 Jul; 604():120724. PubMed ID: 34023443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
    Hard SAAA; Shivakumar HN; Redhwan MAM
    Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics.
    Arora D; Bhatt S; Kumar M; Verma R; Taneja Y; Kaushal N; Tiwari A; Tiwari V; Alexiou A; Albogami S; Alotaibi SS; Mittal V; Singla RK; Kaushik D; Batiha GE
    Front Aging Neurosci; 2022; 14():960246. PubMed ID: 36034142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.
    Dhawan S; Kapil R; Singh B
    J Pharm Pharmacol; 2011 Mar; 63(3):342-51. PubMed ID: 21749381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis.
    Vieira ACC; Chaves LL; Pinheiro S; Pinto S; Pinheiro M; Lima SC; Ferreira D; Sarmento B; Reis S
    Int J Pharm; 2018 Jan; 536(1):478-485. PubMed ID: 29203137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
    J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.
    Sohaib M; Shah SU; Shah KU; Shah KU; Khan NR; Irfan MM; Niazi ZR; Alqahtani AA; Alasiri A; Walbi IA; Mahmood S
    Biomed Res Int; 2022; 2022():7792180. PubMed ID: 35971450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin.
    Akel H; Csóka I; Ambrus R; Bocsik A; Gróf I; Mészáros M; Szecskó A; Kozma G; Veszelka S; Deli MA; Kónya Z; Katona G
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of ferulic acid-loaded chitosan nanoparticle embedded- hydrogel for diabetic wound delivery.
    Bhardwaj H; Jangde RK
    Eur J Pharm Biopharm; 2024 Aug; 201():114371. PubMed ID: 38885910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
    Jain A; Sharma T; Kumar R; Katare OP; Singh B
    Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
    Jojo GM; Kuppusamy G; De A; Karri VVSNR
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule.
    Salem LH; El-Feky GS; Fahmy RH; El Gazayerly ON; Abdelbary A
    J Pharm Sci; 2020 Jul; 109(7):2237-2251. PubMed ID: 32320670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of combined nanocarrier system based on chitosan nanoparticles and phospholipids complex for improved delivery of ferulic acid.
    Telange DR; Jain SP; Pethe AM; Kharkar PS; Rarokar NR
    Int J Biol Macromol; 2021 Feb; 171():288-307. PubMed ID: 33418046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells.
    Senthil Kumar C; Thangam R; Mary SA; Kannan PR; Arun G; Madhan B
    Carbohydr Polym; 2020 Mar; 231():115682. PubMed ID: 31888816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS; Farid RM; ElGamal SS
    Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 18. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
    Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
    J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis.
    El-Dakroury WA; Zewail MB; Asaad GF; Abdallah HMI; Shabana ME; Said AR; Doghish AS; Azab HA; Amer DH; Hassan AE; Sayed AS; Samra GM; Sallam AM
    Eur J Pharm Biopharm; 2024 Mar; 196():114205. PubMed ID: 38311187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anacardic acid encapsulated solid lipid nanoparticles for Staphylococcus aureus biofilm therapy: chitosan and DNase coating improves antimicrobial activity.
    Anjum MM; Patel KK; Dehari D; Pandey N; Tilak R; Agrawal AK; Singh S
    Drug Deliv Transl Res; 2021 Feb; 11(1):305-317. PubMed ID: 32519201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.